ArticleClinical and translational radiation oncology2021

Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan.

Yoshiko Oshiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.